Importance of complex additional stenosis after primary angioplasty for acute myocardial infarction in medium-term prognosis;Importância da presença de lesões adicionais complexas no contexto de angioplastia primária no enfarte agudo do miocárdio no prognóstico a médio-prazo

Revista Portuguesa de Cardiologia

Volumn 23, Issue 6, 2004, Pages 853-864

  Timóteo, Ana Teresa ^a,b   Fiarresga, António ^a   Feliciano, Joana ^a   Ferreira, Rui ^a   Gonçalves, José Maria ^a   Ferreira, Lurdes ^a   Quininha, Jorge ^a  

^a HOSPITAL DE SANTA MARTA   (Portugal)

^b NONE   (Portugal)

Author keywords

Complex additional stenosis; Primary angioplasty; ST segment elevation acute myocardial infarction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ANGIOPLASTY; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT CODING; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; REVASCULARIZATION; RISK FACTOR; ST SEGMENT ELEVATION; STENOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY STENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 3843124114     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997;278:2093-8.
2. Zijlstra F, Hoorntje JCA, de Boer MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999; 341:1413-9.
3. Nunn C, O'Neill WW, Rothbaum D, et al. Long-term outcome after primary angioplasty: report from the Primary Angioplasty in Myocardial Infarction (PAMI-I) trial. J Am Coll Cardiol 1999;33:640-6.
4. Stone GW, Grines CL, Browne KF, et al. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty. J Am Coll Cardiol 1995;26:66-72.
5. Hannan E, Racz MJ, Arani DT, et al. Short- and long-term mortality for patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2000;36:1194-201).
6. Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction (Stent-PAMI). N Engl J Med 1999;341:1949-56.
7. Suryapranata H, van't Hof AW, Hoorntje JC, de Boer M, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998;97:2502-5,
8. Brener SJ, Barr LA, Burchenal JE, et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation 1998; 98:734-41.
9. Neumann FJ, Kastrati A, Schmitt C, et al. Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after placement of coronary stents following acute myocardial infarction. J Am Coll Cardiol 2000;35:915-21.
10. Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction, for the CADILLAC Investigators. N Engl J Med 2002;346:957-66.
11. Roe MT, Cura FA, Joski PS, et al. Initial experience with multivessel percutaneous coronary interventions during mechanical reperfusion for acute myocardial infarction. Am J Cardiol 2001;88:170-3.
12. Menon V, Hochman J. Management of cardiogenic shock complicating acute myocardial infarction. Heart 2002; 88:531-7.
13. Goldstein JA, Demetriou D, Grines CL, et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000:343:915-22.
14. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomised clinical trials. Circulation 1995;91:476-85.
15. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO) IIb Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997;336:1621-28.
16. Zilstra F, Patel A, Jones M, et al., for the PCAT collaboration. Clinical characteristics and outcome of patients with early (<2H), intermediate (2-4H) and late (>4H) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J 2002;23:550-7.
17. Hochman JS, Sleeper LA, Webb JG, et al. Should we emergently revascularize occluded coronaries for cardiogenic shock? (SHOCK). N Engl J Med 1999;341:625-34.
18. Montalescot G, Barragan T, Wittenberg O, et al., for the ADMIRAL Investigators. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001;344:1895-903.
19. de Boer MJ, Ottervanger JP, van't Hof AW, et al. Reperfusion therapy in elderly patients with acute myocardial infarction. A randomised comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol 2002;39:1723-8.
20. Minai K, Horie H, Takahashi M, et al. Long-term outcome of primary percutaneous transluminal coronary angioplasty for low-risk acute myocardial infarction in patients older than 80 years. A single-center, open, randomised trial. Am Heart J 2002;143:497-505.
21. Buffon A, Biasucci LM, Liuzzo G, et al. Widespread coronary inflammation in unstable angina. N Engl J Med 20002;;347:5-12.
22. Scandinavian Simvastatin Survival Study Group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study. Lancet 1994;344:1383-9.
23. Sacks FM, Pfeffer MA, Moye LA, et al., for the Cholesterol and Recurrent Events Study Investigators: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-9.
24. The Long-term Intervention with Pravastatin in Ischaemic Disease study group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-57.
25. The Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-43.
26. The Carvedilol Post-Infarct Survival Control in LV Dysfunction Study Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001;357:1385-90.
27. Hanratty CG, Koyama Y, Rasmussen HH, et al. Exaggeration of nonculprit stenosis severity during acute myocardial infarction: implications for immediate multivessel revascularization. J Am Coll Cardiol 2002;40:911-6.
28. Widimsky P, Groch L, Zelizko M, et al. Multicenter randomised trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. Eur Heart J 2000;21:823-31.
29. DANish multicenter randomized trial on thrombolytic therapy versus acute coronary angioplasty in Acute Myocardial Infarction (DANAMI-2). Presented at the 51st Annual Scientific Session of the American College of Cardiology on March 20, 2002.